Rapid Historical Balance Sheet
| RPID Stock | USD 1.04 0.04 3.70% |
Trend analysis of Rapid Micro Biosystems balance sheet accounts such as Cash of 42.8 M, Other Assets of 0.95, Long Term Debt of 16.3 M or Good Will of 85.5 K provides information on Rapid Micro's total assets, liabilities, and equity, which is the actual value of Rapid Micro Biosystems to its prevalent stockholders. By breaking down trends over time using Rapid Micro balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Rapid Micro Biosystems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rapid Micro Biosystems is a good buy for the upcoming year.
Rapid Micro Inventory |
|
Rapid |
About Rapid Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Rapid Micro Biosystems at a specified time, usually calculated after every quarter, six months, or one year. Rapid Micro Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rapid Micro and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rapid currently owns. An asset can also be divided into two categories, current and non-current.
Rapid Micro Balance Sheet Chart
Add Fundamental
Total Current Liabilities
Total Current Liabilities is an item on Rapid Micro balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Rapid Micro Biosystems are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Rapid Micro obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Rapid Micro Biosystems are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Rapid Micro's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Rapid Micro Biosystems current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rapid Micro Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At present, Rapid Micro's Cash is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 589.6 K, whereas Other Current Liabilities is forecasted to decline to about 5.3 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 10.1M | 7.1M | 8.5M | 5.3M | Total Assets | 241.2M | 190.7M | 143.5M | 107.0M |
Rapid Micro balance sheet Correlations
Click cells to compare fundamentals
Rapid Micro Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Rapid Micro Biosystems is a strong investment it is important to analyze Rapid Micro's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rapid Micro's future performance. For an informed investment choice regarding Rapid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rapid Micro Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rapid Micro. If investors know Rapid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rapid Micro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.603 | Quarterly Revenue Growth 0.237 | Return On Assets (0.25) | Return On Equity (0.46) |
The market value of Rapid Micro Biosystems is measured differently than its book value, which is the value of Rapid that is recorded on the company's balance sheet. Investors also form their own opinion of Rapid Micro's value that differs from its market value or its book value, called intrinsic value, which is Rapid Micro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rapid Micro's market value can be influenced by many factors that don't directly affect Rapid Micro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rapid Micro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rapid Micro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rapid Micro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.